FDA grants emergency use authorization to Lilly’s antibody COVID-19 therapyNovember 10, 2020COVID-19 Updates
Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patientsNovember 10, 2020Leukemia, Myelodysplasia, Transplantation
Beat AML: Precision medicine strategy feasible, superior to SOC for AMLNovember 10, 2020Leukemia, Myelodysplasia, Transplantation
Great Barrington coauthor backs off strict reliance on herd immunityNovember 10, 2020COVID-19 Updates
Whales, seals, and dolphins: Will SARS-CoV-2–contaminated wastewater prove a killer?November 10, 2020COVID-19 Updates
Biden victory: What it means for COVID, health careNovember 7, 2020Practice ManagementCOVID-19 Updates
One-month delay in cancer treatment linked to increase in mortalityNovember 6, 2020Patient & Survivor CareBreast CancerCOVID-19 UpdatesHead & Neck/Thyroid CancersGenitourinary CancerGynecologic CancerGastrointestinal Cancer
Pembrolizumab plus axitinib continues to outshine sunitinib for advanced RCCNovember 6, 2020Renal Cell CarcinomaGenitourinary Cancer
